Estudo de caso-controle: Vacina Meningocócica B previna a doença com 79% de efetividade em crianças e adultos jovens

Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal – JAMA

Comentário: Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under-18s – University of Bristol

Comentário no Twitter

In this matched case-control study, children who developed meningococcal disease were less likely to have been vaccinated with 4CMenB vs matched controls without meningococcal disease during the first 5y of vaccine availability in Portugal https://t.co/dGagZ3aTIB @adamhfinn

— JAMA (@JAMA_current) December 3, 2020